|
variables
|
N = 64 (%)
|
|
Sex
|
|
Male/Female
|
60 (93.8)/4 (6.2)
|
|
Age, median years
|
63.5
|
|
Smoking (pack-yrs)
|
|
Light/Heavy
|
29 (45.3)/35 (54.7)
|
|
Alcohol (drink/week)
| |
|
Light/Heavy
|
32 (50.0)/32 (50.0)
|
|
Location
|
|
Upper/Middle/Lower
|
14 (21.9)/31 (48.4)/19 (29.7)
|
|
Tumor size, median (range, mm)
|
36.5 (8–105)
|
|
Differentiation
|
|
Well/Moderate/Poor
|
26 (40.6)/26 (40.6)/12 (18.8)
|
|
pT category
|
|
T1/T2/T3/T4
|
27 (42.2)/9 (14.1)/27 (42.2)/1 (1.5)
|
|
pN category
|
|
N0/N1/N2/N3
|
39 (60.9)/14 (21.9)/7 (10.9)/4 (6.3)
|
|
pM category
|
|
M0/M1
|
64 (100)/0 (0)
|
|
AJCC stage (8th)
|
|
IA/IB
|
3 (4.7)/23 (35.9)
|
|
IIA/IIB
|
9 (14.1)/5 (7.8)
|
|
IIIA/IIIB
|
4 (6.3)/15 (23.4)
|
|
IVA
|
5 (7.8)
|
|
Treatment
|
|
Surgery alone
|
47 (73.4)
|
|
Surgery and CT
|
7 (10.9)
|
|
Surgery and RT
|
1 (1.6)
|
|
Surgery and CCRT
|
9 (14.1)
|
|
Resection margin status
|
|
Negative (R0)/Positive (R1)
|
57 (89.1)/7 (10.9)
|
|
Recurrence
|
|
No/Yes
|
24 (37.5)/40 (62.5)
|
|
Survival status (at follow-up)
|
|
Alive/Dead
|
26 (40.6)/38 (59.4)
|
|
Family history of malignancy
|
2 (3.1)
|
|
Metachronous/synchronous malignancy
|
17 (26.6)
|
